Oncology

Oncology

Surgery & Therapy

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
61-71 of 71 ARTICLES
https://doi.org/10.12688/f1000research.27809.1
Study Protocol metrics
Clinical trial
IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain
[version 1; peer review: 2 approved]
Peer Reviewers Vinita Singh; Danny Kupka
PUBLISHED 22 Jan 2021
https://doi.org/10.12688/f1000research.27217.2
Opinion Article metrics
Revised
Cancer T-cell therapy: building the foundation for a cure
[version 2; peer review: 3 approved]
Peer Reviewers John R. James and Muna Fuyal; Barbra J. Sasu; C. Glenn Begley
  • Funder
  • A2 Biotherapeutics, Inc.
LATEST VERSION PUBLISHED 22 Dec 2020
https://doi.org/10.12688/f1000research.27805.2
Study Protocol metrics PEER REVIEW DISCONTINUED
Clinical trial
Revised
The efficacy of acupuncture as a complementary treatment for pain and anxiety after breast cancer surgery: Study protocol for a pragmatic randomized control trial
[version 2; peer review: peer review discontinued]
Peer Reviewers Invited
  • Funder
  • Societat Científica d’Acupuntura, Acadèmia de les Ciències Mèdiques de Catalunya i Balears
LATEST VERSION PUBLISHED 18 Dec 2020
https://doi.org/10.12688/f1000research.20727.2
Research Article metrics
Revised
CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Richard Luke Daniels; Yoram Palti; Agung Putra
  • Funders
  • Universitas Gadjah Mada
  • Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia
LATEST VERSION PUBLISHED 23 Jul 2020
https://doi.org/10.12688/f1000research.23455.1
Research Article metrics
Clinical trial
Analgesic efficacy of nefopam for cancer pain: a randomized controlled study
[version 1; peer review: 2 approved]
Peer Reviewers Kok Yuen Ho; Abdul Hadi Mohamed
  • Funder
  • Mahidol University
PUBLISHED 19 May 2020
https://doi.org/10.12688/f1000research.22689.2
Research Article metrics
Revised
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
[version 2; peer review: 3 approved]
Peer Reviewers Jinming Yang; Elena B. Pasquale; Nikki Cheng
  • Funders
  • National Institutes of Health
  • U.S. Department of Veterans Affairs
LATEST VERSION PUBLISHED 14 May 2020
https://doi.org/10.12688/f1000research.20509.2
Opinion Article metrics
Revised
How shall we treat locally advanced triple negative breast cancer?
[version 2; peer review: 2 approved]
Peer Reviewers Brian D. Lehmann; Bruna Cerbelli
LATEST VERSION PUBLISHED 04 May 2020
https://doi.org/10.12688/f1000research.21481.1
Research Article metrics
Effects of ‎tamoxifen on the reproductive system of female breast cancer patients: an ultrasound-based cohort study
[version 1; peer review: 2 not approved]
Peer Reviewers Marian J E Mourits; Lisa Rydén
PUBLISHED 10 Feb 2020
https://doi.org/10.12688/f1000research.19298.2
Research Article metrics
Revised
Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Bernard L. Marini; Vinod Pullarkat; David J. Young
LATEST VERSION PUBLISHED 17 Jan 2020
https://doi.org/10.12688/f1000research.21804.1
Research Article metrics
Clinical trial
A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Lubna N. Chaudhary; Caroline Hamm
  • Funder
  • Eli Lilly and Company
PUBLISHED 06 Jan 2020
https://doi.org/10.12688/f1000research.16786.1
Study Protocol metrics
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
[version 1; peer review: 2 approved]
Peer Reviewers Kalkunte S. Srivenugopal; Frantz Rom Poulsen
  • Funders
  • Sahlgrenska Foundation
  • Nordic Cancer Union
  • AG Foundation
  • ALF agreement
  • Sahlgrenska University Hospital
  • The Swedish Society of Medicine
PUBLISHED 15 Nov 2018
61-71 of 71 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.